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BACKGROUND: The use of hormones for controlled ovarian stimulation results in follicular heterogeneity, with
oocytes at diverse stages of nuclear and cytoplasmic development. This study evaluated the impact of temporary
nuclear arrest by a specific phosphodiesterase 3-inhibitor (PDE3-I), cilostamide, on nuclear and cytoplasmic matu-
ration of cumulus-free germinal vesicle (GV) human oocytes from controlled ovarian stimulated cycles.
METHODS: GV oocytes (n 5 234) were cultured in: (i) medium without the inhibitor (control); (ii) medium sup-
plemented with 1 mM cilostamide and (iii) medium supplemented with 10 mM cilostamide. Oocytes in groups (ii)
and (iii) were exposed to cilostamide for 24 h. The PDE3-I was subsequently removed by transfer of oocytes to
fresh in vitro maturation (IVM) medium and the reversibility of GV arrest was assessed during IVM culture for
maximum 48 h. RESULTS: Cilostamide (1 and 10 mM) could maintain >80% of the oocytes at the GV stage,
without affecting subsequent maturation to metaphase II. Oocytes exposed to 1 mM cilostamide were more likely
to have normal bipolar spindles with aligned chromosomes than control oocytes (P < 0.05). When GV chromatin con-
figurations before and after arrest were compared, a significantly higher proportion of oocytes had acquired a nucleo-
lus completely surrounded by a rim of highly condensed chromatin (P < 0.05). CONCLUSIONS: Temporary nuclear
arrest of human GV oocytes with PDE3-I proved to be beneficial for obtaining normal spindle and chromosome con-
figurations after IVM. It resulted also in synchronization within the population of GV oocytes.
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Introduction
The application of in vitromaturation (IVM) of human oocytes
as an assisted reproductive technology treatment could offer
several advantages, including lower costs, shorter stimulation
protocols and reduced risks of ovarian stimulation syndrome.
Oocytes matured in vitro, however, do not have the same
developmental potential as in vivo matured oocytes (Cha and
Chian, 1998; Moor et al., 1998; Trounson et al., 2001; Chian
et al., 2004). Currently available evidence indicates that the
culture conditions adequately support nuclear maturation, but
frequently fail to sustain optimal cytoplasmic maturation
(Combelles et al., 2002). The nature of this deficiency is still
subject to speculation.
Oocyte developmental competence is gradually acquired
during the long-lasting period of oogenesis. The final stage
for optimal development, prior to ovulation, requires synchro-
nization between nuclear and cytoplasmic maturation (Eppig
et al., 1994). Fully grown oocytes from many species can
mature spontaneously following release from the follicle
(Pincus and Enzmann, 1935; Edwards, 1965). It is believed
that extending meiotic arrest in vitro by temporary blockage
of spontaneous nuclear maturation, a so-called ‘prematuration
culture’ (PMC), might improve the synchronization between
nuclear and cytoplasmic maturational status (Anderiesz et al.,
2000; Nogueira et al., 2003a). This allows time for the
oocyte to undergo structural and biochemical changes that
are essential to sustain normal fertilization and further embryo-
nic development, such as the continued transcription of mRNA,
post-translational modifications of proteins, relocations and
modifications of organelles (Dieleman et al., 2002).
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Furthermore, the use of hormones for controlled ovarian
stimulation results in follicular heterogeneity and, conse-
quently, in oocytes with diverse stages of nuclear and cyto-
plasmic development (Laufer et al., 1984). Hence, different
chromatin configurations within the population of fully
grown germinal vesicle (GV) oocytes were reported (Com-
belles et al., 2002; Miyara et al., 2003). A PMC could contrib-
ute to a synchronization of the different types of GV oocytes,
which may result in an overall improved outcome after IVM
(Nogueira et al., 2003b).
The arrest of meiosis can be induced in vitro by manipulat-
ing the intra-oocyte cAMP levels (Conti et al., 2002). Inhi-
bition of the oocyte-specific phosphodiesterase 3 (PDE3)
keeps intra-oocyte cAMP levels elevated and will maintain
the oocyte arrested at the GV stage (Tsafriri et al., 1996).
This approach has been applied during culture of oocytes
from several species, including human. It was demonstrated
that human cumulus-enclosed oocytes retrieved from small
antral follicles were efficiently arrested by the specific
PDE3-inhibitor (PDE3-I) Org 9935 (Nogueira et al., 2003a,
2006). Ultrastructural analysis of the oocytes showed that
this period of PMC was not deleterious to oocyte morphology
(Nogueira et al., 2003a). Furthermore, applying a PDE3-I
proved to be beneficial for human IVM by enhancing nuclear
maturation rates, without compromising embryonic develop-
ment (Nogueira et al., 2006).
On the basis of these results, the present study was designed
to determine if the use of a PDE3-I could improve IVM of
cumulus-free GV oocytes retrieved from patients stimulated
for ICSI treatment. These oocytes are generally considered to
be a side product of the treatment and the clinical use is
restricted to rare cases (Veeck et al., 1983; Nagy et al., 1996;
Edirisinghe et al., 1997; Chen et al., 2000). Nevertheless,
cumulus-free GV oocytes are a valuable source of research
material to study different effects of PDE3-I on IVM.
The aims of this study were: (i) to evaluate the dose-
dependent effect of cilostamide, a specific PDE3-I, on the
kinetics and the degree of nuclear maturation; (ii) to assess
cytoplasmic quality of arrested oocytes in terms of spindle
morphology and associated chromosome alignment after
IVM and (iii) ascertain whether a period of PMC could
synchronize the population of GV oocytes by evaluating the
chromatin organization around the nucleolus.
Materials and methods
Source of oocytes
Spare GV oocytes (n ¼ 234) were obtained from 114 consenting
women undergoing controlled ovarian stimulation for ICSI treatment.
Complete institutional review board approval was obtained for this
study (Project N8 EC UZG 2006/168). The stimulation protocol
used in our centre has been described in detail elsewhere (Vanhoutte
et al., 2005). Oocytes were denuded enzymatically by a brief exposure
to 80 IU ml21 hyaluronidase (Type VIII; Sigma Chemical Co.,
Bornem, Belgium), followed by mechanical denudation 1 to 3 h
after oocyte collection. The nuclear status of denuded oocytes was
recorded. Oocytes at metaphase II (MII) were used for the ICSI
cycle of the patients. GV-stage oocytes were distributed among
different culture conditions, according to the experimental design
described later.
In vivomatured MII oocytes (n ¼ 11) were donated in a case where
no sperm was available for ICSI and served as the in vivo control for
assessment of spindle morphology and chromosome alignment.
Products and IVM culture
All products were purchased from Sigma Chemical Co. (Bornem,
Belgium), unless otherwise indicated.
The specific PDE3-I used was cilostamide (Cat # 231085, Calbio-
chem, Bierges, Belgium; Stock 10 mM in dimethylsulphoxide stored
at 2208C) at final concentrations of 1 and 10 mM.
The IVM culture medium consisted of tissue culture medium 199
(TCM 199; M2154) supplemented with 10 ng/ml epidermal growth
factor (E9644), 1 mg/ml estradiol (E4389), 10 mIU/ml recombinant
FSH (Puregon, Organon, Oss, The Netherlands), 0.5 mIU/ml HCG
(Pregnyl, Organon), 1 mM L-glutamine (G7513), 0.3 mM sodium pyr-
uvate (P4562), 0.8% human serum albumin (Red Cross, Brussels,
Belgium), 100 IU/ml penicillin G (P4687) and 100 mg/ml streptomy-
cin sulphate (S1277).
All immature oocytes were cultured singly in 25 ml drops of
medium overlaid with embryo-tested light mineral oil in a humidified
atmosphere at 5% CO2 in air at 378C.
Experimental design
GV-stage oocytes from each patient were randomly distributed
between three different culture conditions: (i) IVM medium without
inhibitor (in vitro control); (ii) IVM medium supplemented with
1 mM cilostamide and (iii) IVM medium supplemented with 10 mM
cilostamide. This prevented all oocytes from the same patient being
assigned to the same treatment group. Oocytes in groups (ii) and
(iii) were exposed to cilostamide for 24 h (¼PMC). The PDE3-I
was subsequently removed by transferring the oocytes to fresh IVM
medium and the reversibility of inhibition was assessed during IVM
culture for a maximum of 48 h.
The maturational status of the oocytes in the three groups was
examined at 24 h or up to 48 h (from 25 to 48 h) of IVM culture
and was classified as GV, GV breakdown (GVBD) or polar
body (PB) extrusion. When a PB was identified at any of these time
points, the oocyte was fixed for immunostaining and confocal
imaging of the spindle and the chromosomes.
For analysis of the GV chromatin configuration, immature oocytes
were fixed and stained immediately after the 24 h PMC period. Only
1 mM of cilostamide was tested, because the previous experiments
in this study proved that this was the optimal concentration (see
Results). The organization of chromatin around the nucleolus in
arrested oocytes was compared to non-arrested, control GV oocytes
that were fixed at time 0 h of culture.
Oocyte fixation, immunostaining and confocal imaging
Oocytes were simultaneously fixed and extracted in a
microtubule-stabilizing buffer, as described elsewhere (Mattson and
Albertini, 1990). To visualize microtubules, oocytes were incubated
in the presence of a mixture of mouse monoclonal anti-a,b-tubulin
(1:200; T9026 and T4026) overnight at 48C, followed by Alexa
Fluor 488 conjugated goat-anti-mouse immunoglobulin G (1:200;
A11001, Molecular Probes, Eugene, Oregon) for 2 h at 378C. Chroma-
tin was stained with ethidium homodimer-2 (1:500; E3599, Molecular
Probes) for 1 h at 378C. Labelled oocytes were mounted on micro-
scope slides in 90% glycerol-phosphate-buffered saline solution con-
taining 0.2% 1,4 diazabicyclo[2.2.2]octane (DABCO; D2522) as an
antifading reagent. Preparations were observed using a laser scanning
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confocal microscope (LSCM; Biorad Radiance 2000 mounted on a
Nikon inverted microscope; Tokyo, Japan) equipped with an
argon-ion/helium–neon (488/543) laser and selective filter sets for
Alexa Fluor 488 and ethidium homodimer-2. Images were obtained
using a 100x plan oil immersion objective (numerical aperture 1.3).
Z-axis stacks and 3D reconstructions were obtained by using 0.25 to
0.5 mm steps.
Statistical analysis
Differences between treatment groups were analysed with chi-square
and, when appropriate, two-tailed Fisher’s exact test. When the
P-value was ,0.05, the difference was considered significant.
Results
Effect of cilostamide on nuclear maturation
In Table I, the results of the meiotic progression in arrested and
non-arrested oocytes are presented. Of oocytes exposed to 1
and 10 mM cilostamide, 88% and 85% were efficiently arrested
at the GV stage, respectively. After removal from PDE3-I,
oocytes were capable of resuming meiosis. The kinetic pro-
gression of PB extrusion was compared with the control
group. Twenty-four hours after withdrawal of inhibitor, PB
rates in the groups of previously arrested oocytes were lower
compared with non-arrested controls (P , 0.05; Table I). By
the maximum time of IVM (48 h), however, the PB rates of
arrested oocytes were not significantly different from that of
non-arrested control oocytes. There was no difference in the
proportion and the kinetics of PB extrusion between 1 and
10 mM cilostamide.
Effect of cilostamide on spindle morphology
and chromosome organization
PB oocytes from controls and PMC groups were processed for
LSCM and various stages of microtubule organization and
chromatin configuration could be distinguished. This allowed
us to reclassify 22 IVM oocytes that appeared not to be at
the MII stage of the meiotic cycle, as previously assessed by
PB extrusion with normal light microscopy (Table II). A few
of these oocytes (n ¼ 13) were still at the telophase I stage,
visible by the presence of two discrete bundles of condensed
chromosomes, joined by an attenuated spindle midbody
between the oocyte and the PB (Figure 1A and A0). Some
oocytes (n ¼ 9), present in the two PDE3-I groups, were spon-
taneously activated. This was characterized by the appearance
of a dense and extensive network of interphase microtubules
throughout the oocyte cortex and the formation of a single pro-
nucleus. In contrast, all in vivo matured oocytes (n ¼ 11),
which were fixed immediately after retrieval, were at the MII
stage at the moment of fixation. This was evidenced by the
presence of a MII spindle and one group of condensed
chromosomes arranged on a compact plate at the equator of
the spindle.
Oocytes that reached the MII stage were classified according
to the structure of the spindle (Figure 1B and C) and the organ-
ization of the chromosomes on the metaphase plate (Figure 1B0
and C0; Table II). The percentage of oocytes displaying a
normal barrel-shaped spindle and well-aligned chromosomes
at the equator was significantly higher in the in vivo controls
compared with the in vitro controls and the 10 mM cilostamide
Table I. Progression of meiosis in non-arrested and temporary arrested
germinal vesicle (GV) oocytes, followed by in vitro maturation (IVM) for up
to 48 h
Culture conditions
Control 1 mM
cilostamide
10 mM
cilostamide
No. (%) of GV after inhibition 56/64 (88) 51/60 (85)
No. of GV undergoing IVM 43 56 51
Maturation at 24 h of IVM (%)
GV 26 21 25
GVBD 23a 48b 51b
PB 51a 25b 22b
Maturation up to 48 h of IVM
(between 25 and 48 h) (%)
GV 12 16 24
GVBD 14 13 4
PB 72 63 65
GVBD, germinal vesicle breakdown; PB, polar body.
a,bValues within the same row with different superscripts are statistically
different (P, 0.05). Due to the exclusion of degenerated oocytes, the
different proportions may not add up to 100%.
Table II. Microtubule and chromatin organization of in vivo matured oocytes (in vivo control) and GV oocytes showing a PB after IVM for up to 48 h (in vitro
control, 1 and 10 mM cilostamide)
Culture conditions
In vivo
control
In vitro
control
1 mM
cilostamide
10 mM
cilostamide
No. of PB oocytes analysed 11 27 32 30
No. (%) of oocytes at TI stage 6 (22) 5 (16) 2 (7)
No. (%) of oocytes activated 4 (12) 5 (17)
No. (%) of oocytes at MII stage 11 (100) 21 (78) 23 (72) 23 (77)
Normal spindle shapea 11 (100)b 12 (57)c 18 (78)b,c 14 (61)c
Aligned chromosomesd 10 (91)b 10 (48)c 16 (70)b,c 10 (43)c
TI, Telophase I.
aDefined as a barrel-shaped spindle with slightly pointed, anastral poles. Percentages are calculated over the total number of metaphase II (MII) oocytes.
b,cValues within the same row with different superscripts are statistically different (P, 0.05).
dDefined as condensed chromosomes arranged on a compact plate at the equator of the spindle. Percentages are calculated over the total number of MII oocytes.
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group (P , 0.05; Table II), but similar to the 1 mM cilostamide
group.
On the basis of these results, a concentration of 1 mM cilos-
tamide was chosen in the next experiment.
Effect of cilostamide on chromatin configuration
within the GV
To evaluate if a PMC for 24 h might exert an influence on
nuclear characteristics of the GV oocytes, the pattern of
chromatin configurations was evaluated. This was assessed
before (control) and after the period of arrest.
Three different patterns could be distinguished: Pattern ‘1’:
a nucleolus partially surrounded by chromatin and the presence
of fibrillar chromatin distributed throughout the nucleus
(Figure 2A); Pattern ‘2’: a nucleolus completely surrounded
by chromatin and masses of condensed chromatin or threads
of dispersed chromatin occupying a smaller portion of
the nuclear area (Figure 2B) and Pattern ‘3’: a nucleolus com-
pletely surrounded by a rim of highly condensed chromatin and
Figure 1. Immunocytochemical staining of different spindle morphologies (A–C) and correlative chromatin patterns (A0 –C0) in human oocytes.
(A and A0) Telophase I stage: an attenuated spindle midbody is formed between the oocyte and the polar body (PB; arrow in A). Two sets of
condensed chromosomes are visible; (B and B0) Normal metaphase II spindle with aligned chromosomes, orientated perpendicular and in a cor-
tical position in the oocyte. The microtubule and chromatin organization in the PB is visible as well (arrow in B and B0); (C and C0) Abnormal
spindle with disorganized and partially depolymerized microtubules. In addition, several chromosomes are dislocated from the metaphase plate
(arrows in C0). Scale bar ¼ 5 mm.
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no chromatin throughout the remainder of the nucleoplasm
(Figure 2C).
The proportions of GV in which the different patterns
were observed before and after arrest are represented in
Figure 3. In the control group (before meiotic arrest), the
three different patterns of chromatin configuration were visu-
alized, but pattern ‘2’ was the most frequent one (53% of the
total number of GVs analysed). After 24 h of inhibition, there
was a significant increase in the proportion of oocytes that
had acquired a pattern ‘3’ configuration, which was signifi-
cantly different from the control group (81% versus 33%;
P , 0.05).
Discussion
The present study demonstrates that supplementation of the
IVM culture medium with the specific PDE3-I cilostamide
for 24 h resulted in reversible meiotic arrest of denuded GV
oocytes retrieved in ICSI cycles. This temporary induced
nuclear arrest was equally effective (.80%) at both concen-
trations of 1 and 10 mM cilostamide. The high efficiency of
specific PDE3-I’s to arrest meiosis has been previously demon-
strated in human and non-human primate oocytes (Nogueira
et al., 2003a, 2006; Jensen et al., 2002).
The period of inhibition proved to be completely revers-
ible. After removal of PDE3-I, GV oocytes were capable
of resuming meiosis at the same final rate as non-arrested
oocytes. The overall maturation rate obtained in the present
study was comparable with those achieved by others
working with cumulus-free GV oocytes retrieved from stimu-
lated cycles and matured in TCM-199 (Goud et al., 1998;
Cekleniak et al., 2001; Chian and Tan, 2002; Roberts
et al., 2002).
Although the final rate of nuclear maturation achieved in the
PDE3-I groups was similar to the control group, the time
course for PB extrusion after removal of PDE3-I was slowed
down. The reason for this event is at the moment unclear.
Resumption of meiosis requires PDE3A activity (Tsafriri
et al.,1996; Richard et al., 2001). It is possible that the delay
in meiotic progression observed in the PDE3-I group at 24 h
is a result of the time necessary for the reconstitution of
PDE3 activity and the breakdown of cAMP prior to GVBD.
However, since we did not evaluate the time-lapse between
the onset of meiosis and oocytes’ PB extrusion, it is still to
be evaluated if the lower rate of PB-extruded oocytes at 24 h
of IVM is a result of a later onset of GVBD in comparison to
the control group or if it is due to a longer gap between
GVBD and PB extrusion.
It is still debatable whether this delay in meiotic progression
after withdrawal of the inhibitor results in a positive outcome.
A study by Son et al. (2005) demonstrated that embryos
derived from late-maturing oocytes (48 h of IVM and
beyond) were of lower quality compared with oocytes maturing
between 24 and 30 h of IVM. This suggests that a retarded
meiotic progression results in a negative outcome. On the
other hand, different studies demonstrated that exposure of
oocytes to gonadotrophins (Gomez et al., 1993; Cha and
Chian, 1998) and absence of cumulus cells (Goud et al.,
1998; Kim et al., 2000) accelerates meiotic progression in
vitro, which is a non-physiological condition of oocyte matu-
ration. Both of these variables are relevant to the culture con-
ditions applied in the present study. Therefore, it is possible
that the initial delay in meiotic progression after removal of
inhibitor contributes to a better co-ordination of nuclear and
cytoplasmic maturation.
Figure 2. Different chromatin patterns in human germinal vesicle (GV) oocytes after staining with ethidium homodimer-2 and analysis with laser
scanning confocal microscopy. (A) Pattern ‘1’: partially surrounded nucleolus. Note the presence of fibrillar chromatin distributed throughout the
nucleus; (B) Pattern ‘2’: identified by a rim of condensed chromatin surrounding the nucleolus and threads of chromatin dispersed in the nucleus;
(C) Pattern ‘3’: all chromatin surrounds the nucleolus and there is no chromatin staining present throughout the remainder of the nucleoplasm.
Scale bar ¼ 10 mm.
Figure 3. Chromatin configuration of oocyte nuclei before and after
arrest by cilostamide (1 mM). Patterns 1, 2 and 3 refer to Figure 2.
*Significant different from control (P , 0.05).
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It is difficult to assess the degree of cytoplasmic maturation
of oocytes, apart from the ability to fertilize and support
embryonic development. A possible marker is the morphology
of the meiotic spindle, an essential component of the oocyte.
Disruption of microtubule organization might lead to failures
in chromosome segregation and organelle allocation during
later development (Van Blerkom et al., 1995;
Eichenlaub-Ritter et al., 2002). For that reason, spindle mor-
phology and associated chromosome configurations were
used in the present study as an index of the cytoplasmic integ-
rity of the oocytes.
LSCM observations revealed that a small proportion of in
vitro matured PB oocytes were at the telophase I stage at the
moment of fixation. Polscope analysis showed that following
the extrusion of the first PB, the human oocyte remains at the
telophase I stage for 75–90 min prior to formation of the
MII spindle (Montag et al., 2006). This could explain why
some of the PB oocytes in our study were still at the telophase
I stage. Another portion of oocytes examined showed chroma-
tin and microtubules distinctive of spontaneous activation,
which suggests the inability of the in vitro matured oocytes
to properly maintain M-phase characteristics. This has been
previously recognized as one of the deficiencies related to
IVM (Combelles et al., 2002). Balakier et al. (2004) demon-
strated that the highest fertilization rate of human in vitro
matured oocytes was obtained when ICSI was performed
between 3 and 6 h after extrusion of the PB. These observations
together led us to conclude that the exact time recording of PB
extrusion and fertilization is an essential factor in order to
enhance the outcome of IVM.
MII spindle morphology and chromosome organization
appeared to be suboptimal in in vitro matured control oocytes
compared to in vivo matured oocytes. This is in agreement
with a recent study by Li et al. (2006), comparing spindle mor-
phology and chromosome alignment of in vivo versus in vitro
matured oocytes from polycystic ovary syndrome patients.
An interesting observation in our study was the tendency to
obtain normal spindle/chromosome configurations when
oocytes were exposed to 1 mM cilostamide. This could indicate
that the period of PMC induced cytoplasmic changes in the
oocyte that are necessary for the construction of a normal
spindle and the maintenance of a well-aligned MII plate.
Microtubule reorganization and stability is influenced by
several factors, including protein kinase activity (e.g. mitogen-
activated protein kinase), centrosome-based microtubule
nucleation and post-translational modifications of tubulin
(Albertini, 1992). A PMC could have been attributed to the
synthesis, storage and modifications of some of these factors.
The beneficial effect of PDE3-I on spindle/chromosome
configuration was not clearly demonstrated when a concen-
tration of 10 mM cilostamide was used. This indicates that
the concentration of inhibitor is of importance when applying
such IVM systems. The precise reason for this observation is
unclear at this stage. Some disorganization of meiotic spindles,
abnormalities in microtubule organizing centres and damage to
kinetochores and microtubules have been observed in 6-
dimethylaminopurine (DMAP)-treated mouse oocytes (Rime
et al., 1989; Szo¨llo¨si et al., 1991). Whether similar effects
were, indirectly, induced by the effect of cilostamide at high
concentrations needs further research. However, it is also poss-
ible that the findings are influenced by the variability that might
exist between individual oocytes. The impact of patient age on
spindle morphology has been demonstrated previously
(Battaglia et al., 1996; Eichenlaub-Ritter, 1998). Inter-patient
variability might be eliminated if a larger number of oocytes
per patient could be available.
Another possible marker for oocyte developmental capacity
is the pattern of chromatin organization within the GV. The
results in this study demonstrate that human denuded GV
oocytes, isolated from pre-ovulatory follicles, present hetero-
geneity in the chromatin configuration. This heterogeneity
was previously reported in human oocytes (Parfenov et al.,
1989; Combelles et al., 2002; Miyara et al., 2003).
After the 24 h period of meiotic arrest, we could observe an
increased proportion of oocytes that had acquired a nuclear
configuration in which all of the highly condensed chromatin
surrounded the nucleolus (pattern ‘3’). This finding confirms
that a PMC period with a PDE3-I contributes to the synchroni-
zation of the population of GV oocytes. Similar effects of the
PDE3-I Org9935 were found in mouse oocytes (Nogueira
et al., 2003b).
A transition from a decondensed ‘non-surrounded nucleolus’
to a condensed ‘surrounded nucleolus’ (SN) chromatin pattern
has been related to a transition from an active to an inactive
state of nuclear transcription in rodents (Mattson and Albertini,
1990; Zuccotti et al., 1998, De La Fuente, 2006). The presence
of a SN configuration has been associated with a higher pro-
portion of oocytes reaching meiotic maturation, better embryo-
nic developmental quality and, hence, represents a more
advanced step in oocyte differentiation. In the present study,
the increase of the oocyte population in the arrested group
(1 mM cilostamide) with a pattern ‘3’ configuration might
have contributed to the higher proportion of oocytes with
normal spindles and chromosome organization.
At present, it cannot be ruled out that an acceleration of the
transition from the active to the inactive state of transcription
may have also detrimental effects for some oocytes. Following
transcriptional silencing, the oocyte relies on maternal mRNA
stores to resume meiosis and sustain the first cleavage divisions
after fertilization until activation of the embryonic genome.
Experimentally extending the period between transcriptional
inactivation in the GV and initiation of meiotic maturation
may reduce the competence of the oocytes to complete preim-
plantation embryonic development (De La Fuente and Eppig,
2001). This suggests that the period of temporary nuclear
arrest is crucial and may not be too extensive. Further systema-
tic analysis, e.g. through fluorescent detection of transcriptional
activity, could reveal at which time point the transition from an
active to an inactive state took place during the PMC period
(Fair et al., 1996; Miyara et al., 2003).
An important aspect that deserves attentionwhen analysing the
present results is the source of oocytes used in this study. The GV
oocytes represent an already compromised group of oocytes
retrieved from follicles that failed to conclude maturation in
vivo in response to the hormonal stimulation. Moreover, the
oocytes were denuded of cumulus cells in preparation for ICSI
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before culture. Granulosa cells are the production site of steroids,
growth factors, proteins and other compounds that contribute to
cytoplasmic maturation of oocytes. Beneficial effects of
cumulus cells on microtubule dynamics and/or chromatin stab-
ility, oocyte maturation and early embryonic development have
been reported in many species, including the human (Kennedy
and Donahue, 1969; Cha and Chian 1998; Goud et al., 1998;
Moor et al., 1998; Ueno et al., 2005). Therefore, these oocytes
should not be considered as a first choice for the infertility treat-
ment of the patient. Nevertheless, in some patients with a low
number of mature oocytes at the day of retrieval, these GV
oocytes could be used in order to increase the number of fertiliz-
able oocytes.Oneway to approach amore physiological situation
for IVM of these spare GV oocytes is to restore the communi-
cation between the cumulus cells and the oocyte. A study by
Combelles et al. (2005) describes a novel co-culture system in
which cumulus cells were embedded into a 3D collagen gel
matrix and mixed together with individual oocytes. The authors
found that microtubule-rich processes, which resemble transzo-
nal projections, were visible at the oocyte–cumulus cell inter-
face. This indicates that the interaction between the isolated
cell populations was restored. The next step to improve the
outcome of denuded, otherwise clinically useless, human GV
oocytes might be the use of a similar co-culture system in combi-
nation with temporary nuclear arrest by PDE3-I.
In conclusion, temporary nuclear arrest by the specific PDE3-I
cilostamide (1 mM) proved to be beneficial for spindle/chromo-
some configurations and allowed synchronization of the popu-
lation of immature oocytes. Modification of the PMC to restore
and sustain oocyte-granulosa cell interactions during IVM
might be a feasible step to mirror the physiological situation.
Finally, before any clinical application, complete testing of poss-
ible increased risks of aneuploidy is necessary.
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